WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE
San Diego
12235 El Camino Real
San Diego, CA 92130-3002
US

T858-350-2300

About Our San Diego Office

Opened in 2004, Wilson Sonsini's San Diego office brings to Southern California its unique brand of legal services specifically designed to meet the needs of life sciences, technology, and growth companies at all stages of development. This thriving location reflects the growing importance of the San Diego marketplace and allows the firm to better serve our clients across a variety of industries in Southern California.

The firm's local experience includes facilitating the corporate formation of technology and growth start-ups; negotiating venture capital financing; advising on complex technology and business transactions, as well as strategic alliances and joint ventures; preparing companies for initial public offerings, secondary offerings, and mergers and acquisitions; and providing representation on issues of corporate governance and employee benefits and compensation.

In addition, our San Diego office has broad and deep experience in patents and innovation strategies counseling, technology transactions, and intellectual property litigation. Our team of recognized intellectual property experts is adept at implementing successful new business models, developing and executing strategic intellectual property litigation, structuring and negotiating technology transactions, and consulting on long-term intellectual property strategies.

The San Diego office assists clients in regional growth industries, including pharmaceuticals, biotechnology, medical devices, healthcare, telecommunications, networking, clean technology, cloud computing, e-commerce, new and traditional media, semiconductors, and software.

Through the seamless integration of all Wilson Sonsini offices, we leverage the institutional experience and resources of the entire firm to provide high-quality services to clients. Our proprietary collaborative systems give our attorneys immediate access to the firm's collective expertise and knowledge, enabling them to respond quickly with effective solutions for our clients.

Get Directions
Transportation and Directions

San Diego International Airport is 30 minutes away by car.

Parking

The firm's San Diego office provides ample free parking to clients and visitors.

Related News and Insights
Newsletters
The Life Sciences Report – January 2026
This latest edition features articles on reasons for optimism around 2026 life sciences fundraising, key IP priorities for biotech and biopharma following Series B financing, the default rules of joint patent rights worldwide, the evolving role of innovation theories of harm in the antitrust analysis of life science mergers, life sciences venture financings for firm clients across 2H2024 and 1H2025, and how Wilson Sonsini helped ensure Light Horse Therapeutics’ impressive debut. The report also includes details on the most recent Biotech Summit and Phoenix Conference, the LaunchBio East Coast NextGen VC Forum, the latest episodes of the NextGen VC Podcast focused on life sciences investing, and the Patents and Innovations Library for in-house IP counsel, as well as select life sciences client highlights and upcoming events.
Learn More
Case Studies
How Wilson Sonsini Helped Ensure Light Horse Therapeutics’ Impressive Debut
Light Horse Therapeutics is pioneering new technologies to tackle the root causes of disabling and life-threatening diseases. Using precision gene editing applied to small-molecule drug discovery, its innovative approach is currently targeting historically challenging cancers, with plans to apply the technology to other therapeutic areas in the future.
Learn More
Newsletters
The Entrepreneurs Report: Private Company Financing Trends – Q3 2025
Wilson Sonsini is pleased to present the Q3 2025 edition of The Entrepreneurs Report. We’ve compiled a range of data on venture, convertible note, and SAFE financing transactions in which the firm was involved during the third quarter, with the objective of identifying relevant trends in activity and valuation levels for the U.S. venture capital industry in general.
Learn More
Client Highlights
Wilson Sonsini Advises AXA IM Alts on Patent Matters Related to Imbria Pharmaceuticals’ Upsized Series B Financing
On November 17, 2025, Imbria Pharmaceuticals, a clinical-stage company developing transformational cardiovascular disease therapeutics, announced the participation of AXA IM Alts in an upsized Series B financing. With this investment, AXA IM Alts joins a leading investor syndicate that includes RA Capital, SV Health Investors, Deep Track Capital, AN Ventures, Catalio Capital Management, and Cytokinetics. Wilson Sonsini Goodrich & Rosati advised AXA IM Alts on patent matters related to the transaction.
Learn More
Client Highlights
Wilson Sonsini Advises Empirico on License Agreement with GSK
On October 28, 2025, GSK and Empirico, a clinical-stage biotechnology company with leading capabilities in human genetics-driven target discovery and siRNA medicines, announced that they have entered into a worldwide exclusive license agreement for EMP-012, a highly selective first- and potentially best-in-class siRNA, a type of oligonucleotide. EMP-012 addresses a novel therapeutic target and is currently in a Phase 1 trial for the treatment of chronic obstructive pulmonary disease (COPD), with the potential for expansion into other inflammatory respiratory diseases. Wilson Sonsini Goodrich & Rosati advised Empirico on the transaction.
Learn More
Newsletters
The Entrepreneurs Report: Private Company Financing Trends - Q2 2025
Wilson Sonsini is pleased to present the Q2 2025 edition of The Entrepreneurs Report. We’ve compiled a range of data on venture, convertible note, and SAFE financing transactions in which the firm was involved during the second quarter, with the objective of identifying relevant trends in activity and valuation levels for the U.S. venture capital industry in general.
Learn More
View All Related News and Insights
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.